Bank of America
SCR

Bank of America’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Bank of America’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,500
Closed -$14K – 8635
2013
Q4 		$14K Hold
1,500
– – ﹤0.01% 7191
2013
Q3 		$14K Sell
1,500
-605
-29% -$5.73K ﹤0.01% 7062
2013
Q2 		$20K Buy
+2,105
New +$19.5K ﹤0.01% 6965

Bank of America's SCR Position: Q1 2014 in Review

Bank of America sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q1 2014, closing a stake of 1,500 shares — an estimated $14K sold.

Bank of America first reported a position in SCR in Q2 2013 and held it in 3 quarters. The position peaked at $20K in Q2 2013. 0 funds tracked by Wall St. Rank hold SCR as of Q1 2014.

  • Bank of America reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q1 2014 after selling out during the quarter.
  • Bank of America sold 1,500 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q1 2014, an estimated $14K.
  • Bank of America first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 3 quarters.
  • Bank of America's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $20K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q1 2014.

Based on Bank of America's 13F filing for Q1 2014, filed 15 May 2014.